The Latest Breaking News from FDA

Narcan: the life-saving nasal spray that reverses opioid overdoses

A nasal spray that reverses opioid overdoses is set to become the first opioid treatment drug to be sold over the counter in the US.

The Week · Mar 31, 2023

The FDA now requires medical devices be secured against cyberattacks

Critical vulnerabilities in Internet-connected medical devices lead to new FDA cybersecurity protection measures.

TechRadar · Mar 30, 2023

Senators Ask DEA To Stop Buying Its Way Around Civil Liberties

Plus: Senate Republicans spar over TikTok and free speech, Americans can't agree on how to cut spending, and more...

Reason · Mar 30, 2023

FDA approval of over-the-counter Narcan is an important step in the effort to combat the US opioid crisis

On March 29, 2023, the U.S. Food and Drug Administration approved Narcan for over-the-counter sale. Narcan is the 4-milligram nasal spray version of naloxone, a medication that can quickly counteract an opioid overdose.

The Conversation · Mar 29, 2023

Blue-State AGs Have A Mifepristone Lawsuit of Their Own

And this lawsuit faces many of the same administrative law hurdles as does AHM v. FDA.

Reason · Mar 29, 2023

Overdose antidote Narcan to be sold over the counter, FDA says

The spray version of naloxone will be available for sale by late summer. Experts praised the move to make it more accessible amid the national opioid crisis but are concerned it may be too expensive for some people.

Chicago Sun-Times · Mar 29, 2023

FDA Will Finally Let You Get Naloxone Over the Counter

The life-saving drug stops opioid overdoses as they happen, restoring breathing and preventing death. Why did it take so long for the FDA to expand its use?

Reason · Mar 29, 2023

FDA approves first over-the-counter anti-overdose Narcan spray

The U.S. Food and Drug Administration announced Wednesday that it had approved Narcan for over-the-counter, nonprescription use.

Tribune News Service · Mar 29, 2023

US approves sale of overdose reversal drug without prescription

The decision comes as a bid to widen access to the life-saving drug as the US struggles with a wave of overdose deaths.

Al Jazeera · Mar 29, 2023

The FDA may soon authorize a spring round of COVID-19 boosters for some people

The Food and Drug Administration appears poised to make available the COVID-19 vaccines that target omicron as a second booster for people with weak immune systems and those ages 65 and older.

WEKU · Mar 29, 2023